Cystic Fibrosis News

The Healio Editors compiled the most-read news in pulmonology posted in August.

Using anti-Pseudomonas aeruginosa antibiotics may not provide additional benefit for children with cystic fibrosis who were culture negative for P. aeruginosa for at least 1 year, researchers reported.

In the U.S., newborn screening programs for cystic fibrosis were associated with improved nutritional status up to middle childhood, rapid increases in lung function and delayed chronic Pseudomonas aeruginosa infection, researchers reported.

Digital biomarkers derived from portable spirometers and smartwatches show promise as candidate endpoints for use in clinical trials or clinical care of pediatric asthma and cystic fibrosis, researchers reported.

Findings published in Chest highlighted the importance of routinely capturing treatment burden among individuals with cystic fibrosis in clinical trials.

Inhaled hypertonic saline treatment for 48 weeks led to positive effects on structural lung changes in young children with cystic fibrosis compared with isotonic saline, researchers reported in The Lancet Respiratory Medicine.

A new study published in Annals of the American Thoracic Society highlighted subphenotypes of cystic fibrosis pulmonary exacerbations and differences in biomarker profiles, clinical presentation and outcomes.

The Healio Editors compiled the most-read news in pulmonology posted in March.

In patients with cystic fibrosis, lower preoperative BMI was linked to lower likelihood for BMI recovery within 1 year of lung transplant, but those who achieved BMI recovery within 1 year after transplant had improved survival, researchers reported.

While in-person visits for patients with cystic fibrosis decreased from 2019 to 2020 during the COVID-19 pandemic, a new study found no evidence of worse lung disease, nutrition or increased risk for pulmonary exacerbations.